SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-20-003052
Filing Date
2020-11-19
Accepted
2020-11-19 16:14:12
Documents
5
Effectiveness Date
2020-11-19

Document Format Files

Seq Description Document Type Size
1 dfan14a12766002_11192020.htm DFAN14A 41908
2 EXHIBIT 99.1 - INVESTOR PRESENTATION ex991dfan14a12766002_111920.pdf DFAN14A 1869741
3 GRAPHIC image_004.jpg GRAPHIC 31712
4 GRAPHIC image_005.jpg GRAPHIC 23052
5 GRAPHIC image_006.jpg GRAPHIC 20399
  Complete submission text file 0000921895-20-003052.txt   2718013
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Subject) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-33038 | Film No.: 201328968
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 141 MECOX ROAD WATER MILL NY 11976
Business Address
Postma Robert W (Filed by) CIK: 0001827847 (see all company filings)

Type: DFAN14A